Amarin | AMRN - 自己資本および準備金





自己資本および準備金 変化する 日付
AbbVie USD -6.66B 3.39B 2026-03
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amarin USD 443.62M 5.8M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
BioCryst Pharmaceuticals USD -553.84M 434.69M 2026-03
DBV Technologies USD 160.4M 47.5M 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
Heron Therapeutics USD 9.14M 4.15M 2026-03
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Novartis USD 41.95B 3.02B 2026-06